科瑞生物 (832780.OC)

+ 收藏

利润表(科瑞生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 186,871,829.37242,962,648.1296,869,613.75205,323,479.45103,158,561.78
 营业收入(元) 186,871,829.37242,962,648.1296,869,613.75205,323,479.45103,158,561.78
二、营业总成本(元) 81,184,823.85145,548,824.8662,890,397.84126,373,713.2861,373,372.58
 营业成本(元) 63,749,653.7996,620,552.1941,087,768.6980,590,833.9642,864,248.54
 研发费用(元) 5,421,399.8712,493,406.076,017,897.4916,067,540.589,101,352.53
 营业税金及附加(元) 2,323,973.992,395,591.461,136,049.901,548,881.581,049,231.24
 销售费用(元) 1,790,490.853,734,268.621,431,075.392,956,765.151,147,165.76
 管理费用(元) 9,462,418.2225,798,288.2010,378,986.5821,848,276.857,225,257.19
 财务费用(元) -1,563,112.874,506,718.322,838,619.793,361,415.16-13,882.68
  其中:利息费用(元) 2,071,472.534,205,086.281,968,897.494,240,345.62-
  其中:利息收入(元) 251,921.47143,568.1247,336.62122,731.74-
三、其他经营收益
 加:投资收益(元) 617,050.20-119,503.112,938.42-2,587,899.9875.00
  其中:对联营企业和合营企业的投资收益(元) --159,575.34--2,614,179.27-
 资产处置收益(元) --20,586.60-138,293.28133,266.72-
 资产减值损失(元) -446,634.86-8,415,575.10-861,785.33-8,631,185.50-464,122.14
 信用减值损失(元) 298,434.46-4,536,942.47-2,720,753.78-3,412,062.71310,664.50
 其他收益(元) 448,214.301,474,005.40525,322.412,974,466.391,957,203.92
四、营业利润(元) 106,604,069.6285,795,221.3830,786,644.3567,426,351.0943,589,010.48
 加:营业外收入(元) 400.50163,096.53254,107.99214,061.6924,284.09
 减:营业外支出(元) 148,633.34819,900.6387,160.151,260,187.8346,882.93
五、利润总额(元) 106,455,836.7885,138,417.2830,953,592.1966,380,224.9543,566,411.64
 减:所得税费用(元) 15,422,271.1814,061,931.482,146,746.595,915,120.834,441,174.84
六、净利润(元) 91,033,565.6071,076,485.8028,806,845.6060,465,104.1239,125,236.80
(一)按经营持续性分类
  持续经营净利润(元) 91,033,565.6071,076,485.8028,806,845.6060,465,104.1239,125,236.80
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 62,233,759.6463,262,020.6028,482,494.2761,374,844.7939,332,589.18
  少数股东损益(元) 28,799,805.967,814,465.20324,351.33-909,740.67-207,352.38
 扣除非经常性损益后的净利润(元) 61,233,449.0362,421,732.5328,035,522.1865,612,270.7437,690,859.83
七、每股收益
 一、基本每股收益(元) 0.870.880.400.860.55
 二、稀释每股收益(元) 0.870.880.400.860.55
九、综合收益总额(元) 91,033,565.6071,076,485.8028,806,845.6060,465,104.1239,125,236.80
 归属于母公司所有者的综合收益总额(元) 62,233,759.6463,262,020.6028,482,494.2761,374,844.7939,332,589.18
 归属于少数股东的综合收益总额(元) 28,799,805.967,814,465.20324,351.33-909,740.67-207,352.38
公告日期 2024-08-272024-04-192023-08-252023-03-312022-08-30
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院